en
/
sv
About Elicera
Elicera in brief
Board
Management
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
Strengths
ELC-001
ELC-100
ELC-201
ELC-301
ELC-401
Patents
Pipeline
Pipeline
Clinical trials
Investors
Press Releases
Corporate Governance
the Share
Financial Reports
Financial Calendar
Events
Planned IPO
News
News
Press Releases
Events
Contact
en
/
sv
Certified Adviser
G&W Fondkommission
Kungsgatan 3, 111 43 Stockholm
ca@gwkapital.se
www.gwkapital.se
Tel: +46-8-503 000 50